Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia.
暂无分享,去创建一个
T. Robak | A. Dmoszyńska | A. Skotnicki | B. Jakšić | J. Mayer | P. Hillmen | C. Sirard | Jingyang J. Wu
暂无分享,去创建一个
T. Robak | A. Dmoszyńska | A. Skotnicki | B. Jakšić | J. Mayer | P. Hillmen | C. Sirard | Jingyang J. Wu